Extracorporeal cardiopulmonary resuscitation for the treatment of amlodipine overdose in a pediatric patient.
Katherine GiulianoY Julia ChenKristen ColettiCaitlin O'BrienEric JelinAlejandro GarciaPublished in: Journal of surgical case reports (2021)
We present the case of a 16-year-old female with systemic lupus erythematosus who presented with shock of unclear etiology, refractory to fluid resuscitation and triple vasopressors. She suffered pulseless electrical activity and underwent cannulation onto veno-arterial extracorporeal membrane oxygenation (ECMO). After cannulation, it was discovered she had intentionally overdosed on her home medication, amlodipine, a calcium channel blocker (CCB). She was supported on ECMO, treated with IV calcium and insulin, and was able to be weaned off ECMO after 4 days. She developed oligoanuric acute kidney injury, treated with continuous renal replacement therapy followed by intermittent hemodialysis. At discharge, she was neurologically intact and did not require dialysis. Herein, we review the treatment of CCB overdose, review the literature on the use of ECMO in refractory shock due to cardiovascular medication overdose, and highlight the utility of ECMO in pediatric refractory shock and/or cardiac arrest of unclear etiology.
Keyphrases
- extracorporeal membrane oxygenation
- cardiac arrest
- cardiopulmonary resuscitation
- acute respiratory distress syndrome
- acute kidney injury
- respiratory failure
- systemic lupus erythematosus
- healthcare
- mechanical ventilation
- type diabetes
- chronic kidney disease
- systematic review
- hypertensive patients
- replacement therapy
- combination therapy
- adverse drug
- blood pressure
- disease activity
- electronic health record
- septic shock